This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jogie-Brahim, S. Articles by Oh, Y. Search for Related Content PubMed PubMed Citation Articles by Jogie-Brahim, S. Articles by Oh, Y.

Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease

Department of Pathology (S.J.-B., Y.O.), Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298; and Department of Medicine, Division of Endocrinology (D.F.), Stanford University, Stanford, California 94305

Correspondence: Address all correspondence and requests for reprints to: Dr. Youngman Oh, Department of Pathology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0662. E-mail: yoh{at}vcu.edu.

The IGF system plays critical roles in somatic growth in an endocrine fashion (somatomedin hypothesis) as well as proliferation and differentiation of normal and malignant cells in a paracrine/autocrine fashion. IGFBP-3 is known to modulate the actions of IGFs in circulation as well as the immediate extracellular environment. Interestingly, apart from the ability to inhibit or enhance IGF actions, IGFBP-3 also exhibits very clear, distinct biological effects independent of the IGF/IGF-I receptor axis. Over the past decade it has become widely appreciated that IGF/IGF-IR-independent actions of IGFBP-3 (antiproliferative and proapoptotic effects) contribute to improving the pathophysiology of a variety of human diseases, such as cancer, diabetes, and malnutrition. Recent studies have implicated interaction of IGFBP-3 with a variety of proteins or signaling cascades critical to cell cycle control and apoptosis; however, the actual mechanism of IGFBP-3 action is still unclear. This review reinforces the concept in support of the IGF/IGF-IR axis-independent actions of IGFBP-3 and delineates potential underlying mechanisms involved and subsequent biological significance, focusing in particular on functional binding partners and the clinical significance of IGFBP-3 in the assessment of cancer risk.

This article has been cited by other articles:

				A. V Krishnan and D. Feldman Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment Endocr. Relat. Cancer, January 29, 2010; 17(1): R19 - R38. [Abstract] [Full Text] [PDF]